These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11673355)

  • 1. New concepts in hypertrophic cardiomyopathies, part I.
    Roberts R; Sigwart U
    Circulation; 2001 Oct; 104(17):2113-6. PubMed ID: 11673355
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic considerations in hypertrophic cardiomyopathy.
    Ho CY
    Prog Cardiovasc Dis; 2012; 54(6):456-60. PubMed ID: 22687586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy.
    Waring A; Harper A; Salatino S; Kramer C; Neubauer S; Thomson K; Watkins H; Farrall M
    J Med Genet; 2021 Aug; 58(8):556-564. PubMed ID: 32732227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Ancestral Diversity in Genetic Testing Matters: Lessons Learned From Hypertrophic Cardiomyopathy.
    Dunn KE
    Circ Heart Fail; 2024 Mar; 17(3):e011484. PubMed ID: 38456261
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
    Landstrom AP; Ackerman MJ
    Circulation; 2010 Dec; 122(23):2441-9; discussion 2450. PubMed ID: 21135372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanobiology: forcing the second act.
    Weaver VM
    Mol Biol Cell; 2021 Aug; 32(18):1611-1613. PubMed ID: 34410838
    [No Abstract]   [Full Text] [Related]  

  • 7. Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics.
    Keyt LK; Duran JM; Bui QM; Chen C; Miyamoto MI; Silva Enciso J; Tardiff JC; Adler ED
    Front Cardiovasc Med; 2022; 9():972301. PubMed ID: 36158814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undiagnosed apical hypertrophic cardiomyopathy in an old amateur soccer player: a case report.
    Harras ME; Bensahi I; Abdeladim S; Merzouk F; Elouarradi A; Oualim S; Sabry M
    Pan Afr Med J; 2021; 40():182. PubMed ID: 35059102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?
    Sanoudou D; Kolokathis F; Arvanitis D; Al-Shafai K; Krishnamoorthy N; Buchan RJ; Walsh R; Tsiapras D; Barton PJ; Cook SA; Kremastinos D; Yacoub M
    Glob Cardiol Sci Pract; 2015; 2015(2):29. PubMed ID: 26535225
    [No Abstract]   [Full Text] [Related]  

  • 10. Roles of the troponin isoforms during indirect flight muscle development in Drosophila.
    Singh SH; Kumar P; Ramachandra NB; Nongthomba U
    J Genet; 2014 Aug; 93(2):379-88. PubMed ID: 25189233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined obstructive hypertrophic cardiomyopathy and double outlet right ventricle in an infant with Down syndrome.
    Ghimire L; Tawffik O; Schroeder VA
    Am J Case Rep; 2013; 14():453-8. PubMed ID: 24222815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice.
    Kazmierczak K; Muthu P; Huang W; Jones M; Wang Y; Szczesna-Cordary D
    Biochem J; 2012 Feb; 442(1):95-103. PubMed ID: 22091967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype.
    Armel TZ; Leinwand LA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):352-6. PubMed ID: 19913502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nonischemic cardiomyopathies using cardiovascular magnetic resonance.
    O'Hanlon R; Prasad SK; Pennell DJ
    J Nucl Cardiol; 2008; 15(3):400-16. PubMed ID: 18513647
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical management of hypertrophic cardiomyopathy in 2007: what is new?
    Brown ML; Schaff HV
    World J Surg; 2008 Mar; 32(3):350-4. PubMed ID: 18202887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.
    Angelini P
    Tex Heart Inst J; 2007; 34(3):336-46. PubMed ID: 17948085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant splicing of an alternative exon in the Drosophila troponin-T gene affects flight muscle development.
    Nongthomba U; Ansari M; Thimmaiya D; Stark M; Sparrow J
    Genetics; 2007 Sep; 177(1):295-306. PubMed ID: 17603127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy.
    O'Hanlon R; Assomull RG; Prasad SK
    Curr Cardiol Rep; 2007 Mar; 9(1):51-6. PubMed ID: 17362685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.
    Borisov AB; Sutter SB; Kontrogianni-Konstantopoulos A; Bloch RJ; Westfall MV; Russell MW
    Histochem Cell Biol; 2006 Mar; 125(3):227-38. PubMed ID: 16205939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.